Abstract
Tuberculosis remains in the world an important problem of public health. This study objective was to investigate the genetic basis of resistance to Isoniazid and Rifampicin of Mycobacterium tuberculosis complex strains collected in Lagunes region, an area of high burden of tuberculosis. During primary resistance study, 196 smears positive new cases of tuberculosis were recruited in Lagunes region. Out of a sample of 31 strains, 17 were Isoniazid mono-resistant strains, 7 were multi-drug resistant (MDR) strains and 7 were susceptible to both Isoniazid and Rifampicin. Genotype MTBC assays and sequencing of mabA-inhA regulatory region, katG, inhA and rpoB genes were performed on all the strains. At least one mutation in the genes studied was found in 20 (83%) of the 24 resistant strains. Ser315Thr mutation was prominent in Isoniazid mono-resistant strains (9/13) and in MDR strains (7/8). Three of 16 Isoniazid resistant strains with Ser315Thr mutation had an additional mutation in the regulatory region. No mutation were found in 6 of the 7 susceptible strains. Molecular methods in tuberculosis laboratory may improve detection of tuberculosis case with drug resistance case. Key words: Mycobacterium tuberculosis complex, susceptibility testing, resistant genes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
